Current cases in which epitope mimicry is considered as a component cause of autoimmune disease: Immune-mediated (type 1) diabetes

Cellular and Molecular Life Sciences

Volumn 57, Issue 4, 2000, Pages 534-541

  Kukreja, A ^a   Maclaren, N K ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Autoantigens; Autoimmune diseases; Cytokines; Immune mediated diabetes mellitus; Molecular mimicry; Non obese diabetic mice

Indexed keywords

AUTOANTIGEN; GLUTAMATE DECARBOXYLASE; INSULIN; SUPERANTIGEN;

AUTOIMMUNE DISEASE; COXSACKIE VIRUS B; DIABETIC OBESITY; DISEASE MODEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; MOLECULAR MIMICRY; NONHUMAN; PANCREAS ISLET BETA CELL; REVIEW; TH1 CELL; VIRUS INFECTION;

EID: 0034064465     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00000715     Document Type: Review

References (62)

1. 1 Rose N. R. (1998) The role of infection in the pathogenesis of autoimmune disease. Semin. Immunol. 10: 5-13
2. 2 Kallmann B. A., Huther M., Tubes M., Feldkamp J., Bertrams J., Gries F. A. et al. (1997) Systemic bias of cytokine production toward cell-mediated immune regulation in IDDM and toward humoral immunity in Graves' disease. Diabetes 46: 237-243
3. 3 Williams R. C. (1978). Infection and autoimmunity. In: Autoimmunity: Genetic, Immunologic, Virologic and Clinical Aspects, p. 457, Talal N. (ed.), Academic Press, New York
4. 4 Bottazzo G. F., Todd I., Mirakian R., Belfiore A. and Pujol-Borrell R. (1986) Organ specific autoimmunity: 1986 overview. Immunol. Rev. 94: 137-169
5. 5 Benoist C. and Mathis D. E. (1998) The pathogen connection. Nature 394: 227-228
6. 6 Paterson P. Y., Day E. D. and Whitacrce C. C. (1981) Neuroimmunologic disease: effector cell response and immunoregulatory mechanisms. Immunol. Rev. 55: 89-120
7. 7 Lane D. P. and Hoeffler W. K. (1980) SV40 large T shares an antigenic determinant with a cellular protein of molecular weight 68,000. Nature 288: 167-170
8. 8 Cohen A. D. and Shoenfeld Y. (1996) Vaccine-induced autoimmunity. J. Autoimmunity 9: 699-703
9. 9 Borch-Johnsen K., Kreiner S. and Deckert T. (1986) Mortality of type 1 (insulin-dependent) diabetes mellitus in Denmark: a study of relative mortality in 2930 Danish type 1 diabetic patients diagnosed from 1933 to 1972. Diabetologia 29: 767-772
10. 10 Pyke D. A. (1988) Development of diabetes in identical twins. Adv. Exp. Med. Biol. 246: 255-258
11. 11 Theofilopoulos A. N. (1995) The basis of autoimmunity. Part II. Genetic predisposition. Immunol. Today 16: 150-159
12. 12 Merriman T. R. and Todd J. A. (1995) Genetics of autoimmune disease. Curr. Opin. Immunol. 7: 786-792
13. 13 Atkinson M. A. and Maclaren N. K. (1994) The pathogenesis of insulin-dependent diabetes mellitus. N. Engl. J. Med. 331: 1428-1436
14. 14 Tisch R. and McDevitt H. (1996) Insulin-dependent diabetes mellitus. Cell 85: 291-297
15. 15 Song Y.-H., Li Y. and Maclaren N. K. (1996) The nature of the autoantigens targeted in autoimmune endocrine diseases. Immunol. Today 17: 232-238
16. + T cells. J. Exp. Med. 166: 823-832
17. + T cell clones from young non-obese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 + cells. J. Exp. Med. 183: 67-76
18. 18 Qin H.-Y., Sadelain M., Hitchon C., Lauzon J. and Singh B. (1993) Freund's adjuvant-induced T cells prevent the development and adoptive transfer of diabetes in nonobese diabetic mice. J. Immunol. 150: 2072-2080
19. 19 Bendelac A., Lantz O., Quimby M.E., Yewdell J. W., Bennick J. R. and Brutkiewicz R. R. (1995) CD1 recognition by mouse NK1 + T lymphocytes. Science 268: 863-865
20. 20 Leite-De-Moraes M. C. and Dy M. (1997) NK T cells: a potent cytokine-producing cell population. Eur. Cytokine Netw. 8: 229-237
21. pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J. Exp. Med. 179: 1285-1295
22. 22 Wilson S. B., Kent S. C., Patton K. T., Orban T., Jackson R. A., Exley M. et al. (1998) Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. Nature 391: 177-181
23. 23 Maclaren N. K. and Atkinson M. A. (1997) Insulin-dependent diabetes mellitus: the hypothesis of molecular mimicry between islet cell antigens and microorganisms. Mol. Med. Today 3: 76-83
24. 24 See D. M. and Tilles J. G. (1998) The pathogenesis of viral-induced diabetes. Clin. Diagn. Virol. 9: 85-88
25. 25 Vreugdenhil G. R., Geluk A., Ottenhoff T. H., Melchers W. J., Roep B. O. and Galama J. M. (1998) Molecular mimicry in diabetes mellitus: the homologous domain in coxsackie B virus protein 2C and islet autoantigen GAD65 is highly conserved in the coxsackie B-like enteroviruses and binds to the diabetes associated HLA-DR3 molecule. Diabetologia 41: 40-46
26. 26 Yoon J. W. and Ray U. R. (1985) Perspectives on the role of viruses in insulin-dependent diabetes. Diabetes Care 8(Suppl 1): 39-44
27. 27 Jenson A. B., Rosenberg H. S. and Notkins A. L. (1980) Pancreatic islet-cell damage in children with fatal viral infections. Lancet ii: 354-358
28. 28 Sutkowski N., Palkama T., Ciurli C., Sekaly R. P., Thorley-Lawson D. A. and Huber B. T. (1996) An Epstein-Barr virus-associated superantigen. J. Exp. Med. 184: 971-980
29. 29 Gladisch R., Hofmann W. and Waldherr R. (1976) Myocarditis and insulitis following coxsackie virus infection. Z. Kardiol. 10: 837-849
30. 30 Champsaur H. F., Bottazzo G. F., Bertrams J., Assan R. and Bach C. (1982) Virologic, immunologic, and genetic factors in insulin-dependent diabetes mellitus. J. Pediatr. 100: 15-20
31. 31 Banatvala J. E., Bryant J., Schernthaner G., Borkenstein M., Schober E., Brown D. et al. (1985) Coxsackie B, mumps, rubella, and cytomegalovirus specific IgM responses in patients with juvenile-onset insulin-dependent diabetes mellitus in Britain, Austria, and Australia. Lancet i: 1409-1412
32. 32 Yoon J., Austin M., Onodera T. and Notkins A. L. (1979) Virus-induced diabetes mellitus. N. Engl. J. Med. 300: 1173
33. 33 Ginsber-Fellner F., Witt M. E., Yagihashi S., Dobersen M. J., Taub F., Fedun B. et al. (1984) Congenital rubella syndrome as a model for type 1 (insulin-dependent) diabetes mellitus: increased prevalence of islet cell surface antibodies. Diabetologia 27 [Suppl]: 87-89.
34. 34 Yoon J. W., Selvaggio S., Onodera T., Wheeler J. and Jennson A. B. (1981) Infection of the cultured human pancreatic B cells with reovirus type 3. Diabetologia 20: 462-467
35. 35 Prince G., Jenson A. B., Billups L. and Notkins A. L. (1978) Infection of the human pancreatic beta cell cultures with mumps virus. Nature 27: 158-161
36. 36 Yoon J. W., Onodera T. and Notkins A. L. (1978a) Virus-induced diabetes mellitus. XI. Replication of Coxsackie virus B3 in human pancreatic beta cell cultures. Diabetes 27: 778-781
37. 37 Yoon J. W., Onodera T. and Notkins A. L. (1978b) Virus-induced diabetes mellitus: beta cell damage and insulin-dependent hyperglycemia in mice infected with Coxsackie virus B4. J. Exp. Med. 148: 1068-1080
38. 38 Pak C. Y., McArthur R. G., Eun H. M. and Yoon J. W. (1988) Association of cytomegalovirus infection with autoimmune type diabetes. Lancet ii: 1-4
39. 39 Kaufman D. L., Erlander M. G., Clare-Salzler M., Atkinson M. A., Maclaren N. K. and Tobin A. J. (1992) Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J. Clin. Invest. 89: 283-292
40. 40 Atkinson M. A., Bowman M. A., Campbell L., Darrow B. L., Kaufman D. L. and Maclaren N. K. (1994) Cellular immunity to a determinant common to glutamate decarboxyase in insulin-dependent diabetes mellitus. J. Clin. Invest. 94: 2125-2129
41. 41 Kaufman D. L., Clare-Salzler M., Tian J., Forsthuber T., Ting G. S., Robinson P. et al. (1993) Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366: 69-72
42. 42 Tisch R., Yang X. D., Singer S. M., Liblau R. S., Fugger L. and McDevitt H. O. (1993) Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 366: 72-75
43. 43 Tian J., Lehmann P. V. and Kaufman D. L. (1994) T cell cross-reactivity between coxsackievirus and glutamate decarboxylase is associated with a murine diabetes susceptibility allele. J. Exp. Med. 180: 1979-1984
44. 44 Baekkeskov S., Aanstoot H. J., Christgau S., Reetz A., Solimena M., Cascalho M. et al. (1990) Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA synthesizing enzyme glutamate decarboxylase. Nature 347: 151-156
45. 45 Szopa T. M., Tichener P. A., Portwood N. D. and Taylor K. W. (1993) Diabetes mellitus due to viruses - some recent developments. Diabetologia 36: 687-695
46. 46 Schloot N. C., Roep B. O., Wegmann D. R., Yu L., Wang T. B. and Eisenbarth G. S. (1997) T-cell reactivity to GAD65 peptide sequences shared with coxsackie virus protein in recent-onset IDDM, post-onset IDDM patients and control subjects. Diabetologia 40: 332-338
47. 47 Lonnrot M., Hyoty H., Knip M., Roivainen M., Kulmala P., Leinikki P. et al. (1996) Antibody cross-reactivity induced by the homologous regions in glutamic acid decarboxylase (GAD65) and 2C protein of coxsackievirus B4. Childhood Diabetes in Finland Study Group. Clin. Exp. Immunol. 104: 398-405
48. 48 Lohmann T., Leslie R. D., Hawa M., Geysen M., Rodda S. and Londei M. (1994) Immunodominant epitopes of glutamic acid decarboxylase 65 and 67 in insulin dependent diabetes mellitus. Lancet 343: 1607-1608
49. 49 Horwitz M. S., Bradley L. M., Harbertson J., Krahl T., Lee J. and Sarvetnick N. (1998) Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat. Med. 4: 781-785
50. 50 Honeyman M. C., Stone N. L. and Harrison L. C. (1998) T-cell epitopes in type 1 diabetes autoantigen tyrosine phosphatase IA-2: potential for mimicry with rotavirus and other environmental agents. Mol. Med. 4: 231-239
51. 51 Oldstone M. B. A. (1997) Viruses and autoimmune diseases. Scand. J. Immunol. 46: 320-325
52. 52 Herrath M. von, Dockter J. and Oldstone M. B. A. (1994) How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model. Immunity 1: 231-242
53. 53 Mueller R., Davies J. D., Krahl T. and Sarvetnick N. (1997) IL-4 expression by grafts from transgenic mice fails to prevent allograft rejection. J. Immunol. 159: 1599-1603
54. 54 Herrath M. G. von and Oldstone M. B. A. (1996) Virus-induced autoimmune diseases. Curr. Opin. Immunol. 8: 878-885
55. 55 Herrath M. G. von, Dyrberg T. and Oldstone M. B. A. (1996) Oral insulin treatment suppresses virus-induced antigen-specific destruction of β cells and prevents autoimmune diabetes in transgenic mice. J. Clin. Invest. 98: 1327-1331
56. 56 White J., Herman A., Pullen A. M., Kubo R., Kappler J. W. and Marrack P. (1989) The Vβ-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell 56: 27-35
57. 57 Conrad B., Weissmahr R. N., Jung B., Rosanna A., Schupbach J. and Bernard M. (1997) A human endogenous retroviral superantigen as candidate autoimmune gene in type 1 diabetes. Cell 90: 303-313
58. 58 Serreze D., Leiter E., Kuff E., Jardieu D. and Ishizaki K. (1988) Molecular mimicry between insulin and retroviral antigen p73: development of cross reactive autoantibodies in sera of NOD and C57BL/Ks db/db mice. Diabetes 37: 351-358
59. 59 Hao W., Serreze D. V., McCulloch D. K., Neifing J. L. and Palmer J. P. (1993) Insulin (auto) antibodies from human IDDM cross-react with retroviral antigen p73. J. Autoimmunity 6: 787-798
60. 60 Conrad B., Weidmann E., Trucco G., Rudert W. A., Behboo R., Ricordi C. et al. (1994) Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology. Nature 371: 351-355
61. 61 Lan M. S., Mason A., Coutant R., Chen Q.-Y., Vargas A., Rao J. et al. (1998) HERV-K10s and immune-mediated (type 1) diabetes. Cell 95: 14-16
62. 62 Naserke H. E., Ziegler A. G., Lampasona V. and Bonifacio E. (1998) Early development and spreading of autoantibodies to epitopes of IA-2 and their association with progression to type 1 diabetes. J. Immunol. 161: 6963-6969